Updates

Craneware

July 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The shares came off sharply following an unscheduled trading update for the year to 30 June. This said that whilst it continues to sign new contracts with hospitals in the US, it managed to close fewer sales in the second half of the year than anticipated. Given that contracted revenues plus renewal revenues entering the year were c.$66m, or c.83% of original FY revenue forecast, similar to the previous five years, it’s not easy to see what went wrong. Broker Investec puts it down to poor sales execution rather than any macro factor, with new products taking time to scale as customers seek references while distracting the sales effort away from the core Chargemaster and Pharmacy “bread and butter” products. As a result, ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Scientific Digital Imaging

Blancco - Joined up mobile erasure product roadmap

Craneware (September 2024)

Craneware - Growing pipeline of opportunities (October 2023)

Craneware (August 2018)

Craneware - Two significant new contracts (March 2018)

Craneware - Gain since main profile: 154% (February 2018)

Craneware - Bullet proof business (October 2016)

Craneware (August 2016)

Craneware - Big beneficiary of Obamacare (November 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X